Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $78.33, with a high estimate of $82.00 and a low estimate of $67.00. Marking an increase of 2 ...

Q2 2025 Earnings Call Transcript August 13, 2025 ARS Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $ ...

Diversified healthcare company CVS Health (NYSE:CVS) in Q2 CY2025, with sales up 8.4% year on year to $98.92 billion. Its non ...

Through the power of strategic, well-built partnerships, CVS Health helps employees earn degrees — and at no cost to them.

Joshua Fredell, Pharm.D., senior vice president at CVS Caremark and PBMI Innovator Award winner, is calling for a PBM industry focus on making pharmacy experiences more seamless while continuing to ...

As drug companies increasingly adopt the DTC sales model, patients will gain the ability to buy the medicines they need at ...

CVS Caremark owes the State of West Virginia $1.4 million in civil penalties after the state’s insurance commissioner found ...

O'Reilly Automotive Inc. is suing the three major pharmacy benefit managers in the U.S., as well as the three major insulin manufacturers.

The company hopes an important CVS deal and broader legal action against the makers of knockoff Wegovy can solidify its ...

In a new analysis, the American Medical Association detailed the lack of competition among pharmacy benefit managers and ...

CVS projects full-year guidance to include revenue of at least $382.6 billion and adjusted earnings per share of $6 to $6.20. The company offers a strong dividend yield of 4.5%, making it an appealing ...

Hundreds of pharmacies across Pennsylvania have gone out of business in recent years, data obtained by Spotlight PA shows, ...